Atlas Trials

A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.

Clinical trial NCT04428086 · COMPLETED

Trial details

NCT number
NCT04428086
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor, Adult
Start date
2020-07-27
Primary completion
2021-08-22
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.